Sarinnapha M Vasunilashorn1, Long Ngo2, Sharon K Inouye1, Towia A Libermann2, Richard N Jones3, David C Alsop4, Jamey Guess5, Sandra Jastrzebski6, Janet E McElhaney7, George A Kuchel6, Edward R Marcantonio1. 1. Harvard Medical School, Boston, Massachusetts. Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts. Department of Medicine, and. 2. Harvard Medical School, Boston, Massachusetts. Department of Medicine, and. 3. Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts. Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island. 4. Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts. Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 5. Department of Medicine, and. 6. UConn Center on Aging, University of Connecticut Health Center, Farmington. 7. Advanced Medical Research Institute of Canada, Sudbury, Ontario, Canada.
Abstract
BACKGROUND: A proinflammatory state has been associated with several age-associated conditions; however, the inflammatory mechanisms of delirium remain poorly characterized. METHODS: Using the Successful Aging after Elective Surgery Study of adults age ≥70 undergoing major noncardiac surgery, 12 cytokines were measured at four timepoints: preoperative, postanesthesia care unit, postoperative day 2 (POD2) and 30 days later (POD1M). We conducted a nested, longitudinal matched (on age, sex, surgery type, baseline cognition, vascular comorbidity, and Apolipoprotein E genotype) case-control study: delirium cases and no-delirium controls were selected from the overall cohort (N = 566; 24% delirium). Analyses were independently conducted in discovery, replication, and pooled cohorts (39, 36, 75 matched pairs, respectively). Nonparametric signed-rank tests evaluating differences in cytokine levels between matched pairs were used to identify delirium-associated cytokines. RESULTS: In the discovery and replication cohorts, matching variables were similar in cases and controls. Compared to controls, cases had (*p < .05, **p < .01) significantly higher interleukin-6 on POD2 in the discovery, replication, and pooled cohorts (median difference [pg/mL] 50.44**, 20.17*, 39.35**, respectively). In the pooled cohort, cases were higher than controls for interleukin-2 (0.99*, 0.77*, 1.07**, 0.73* at preoperative, postanesthesia care unit, POD2, POD1M, respectively), vascular endothelial growth factor (4.10* at POD2), and tumor necrosis factor-alpha (3.10* at POD1M), while cases had lower interleukin-12 at POD1M (-4.24*). CONCLUSIONS: In this large, well-characterized cohort assessed at multiple timepoints, we observed an inflammatory signature of delirium involving elevated interleukin-6 at POD2, which may be an important disease marker for delirium. We also observed preliminary evidence for involvement of other cytokines.
BACKGROUND: A proinflammatory state has been associated with several age-associated conditions; however, the inflammatory mechanisms of delirium remain poorly characterized. METHODS: Using the Successful Aging after Elective Surgery Study of adults age ≥70 undergoing major noncardiac surgery, 12 cytokines were measured at four timepoints: preoperative, postanesthesia care unit, postoperative day 2 (POD2) and 30 days later (POD1M). We conducted a nested, longitudinal matched (on age, sex, surgery type, baseline cognition, vascular comorbidity, and Apolipoprotein E genotype) case-control study: delirium cases and no-delirium controls were selected from the overall cohort (N = 566; 24% delirium). Analyses were independently conducted in discovery, replication, and pooled cohorts (39, 36, 75 matched pairs, respectively). Nonparametric signed-rank tests evaluating differences in cytokine levels between matched pairs were used to identify delirium-associated cytokines. RESULTS: In the discovery and replication cohorts, matching variables were similar in cases and controls. Compared to controls, cases had (*p < .05, **p < .01) significantly higher interleukin-6 on POD2 in the discovery, replication, and pooled cohorts (median difference [pg/mL] 50.44**, 20.17*, 39.35**, respectively). In the pooled cohort, cases were higher than controls for interleukin-2 (0.99*, 0.77*, 1.07**, 0.73* at preoperative, postanesthesia care unit, POD2, POD1M, respectively), vascular endothelial growth factor (4.10* at POD2), and tumor necrosis factor-alpha (3.10* at POD1M), while cases had lower interleukin-12 at POD1M (-4.24*). CONCLUSIONS: In this large, well-characterized cohort assessed at multiple timepoints, we observed an inflammatory signature of delirium involving elevated interleukin-6 at POD2, which may be an important disease marker for delirium. We also observed preliminary evidence for involvement of other cytokines.
Authors: Eva M Schmitt; Edward R Marcantonio; David C Alsop; Richard N Jones; Selwyn O Rogers; Tamara G Fong; Eran Metzger; Sharon K Inouye Journal: J Am Med Dir Assoc Date: 2012-09-19 Impact factor: 4.669
Authors: Timothy D Girard; Lorraine B Ware; Gordon R Bernard; Pratik P Pandharipande; Jennifer L Thompson; Ayumi K Shintani; James C Jackson; Robert S Dittus; E Wesley Ely Journal: Intensive Care Med Date: 2012-08-18 Impact factor: 17.440
Authors: Jane S Saczynski; Cyrus M Kosar; Guoquan Xu; Margaret R Puelle; Eva Schmitt; Richard N Jones; Edward R Marcantonio; Bonnie Wong; Ilean Isaza; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2014-02-10 Impact factor: 5.562
Authors: Robert A Pol; Barbara L van Leeuwen; Gerbrand J Izaks; Michel M P J Reijnen; Linda Visser; Ignace F J Tielliu; Clark J Zeebregts Journal: Ann Vasc Surg Date: 2014-07-10 Impact factor: 1.466
Authors: Priya Palta; Qian-Li Xue; Jennifer A Deal; Linda P Fried; Jeremy D Walston; Michelle C Carlson Journal: J Gerontol A Biol Sci Med Sci Date: 2014-08-26 Impact factor: 6.053
Authors: Reinhold Schmidt; Helena Schmidt; J David Curb; Kamal Masaki; Lon R White; Lenore J Launer Journal: Ann Neurol Date: 2002-08 Impact factor: 10.422
Authors: Sarinnapha Vasunilashorn; Luigi Ferrucci; Eileen M Crimmins; Stefania Bandinelli; Jack M Guralnik; Kushang V Patel Journal: J Am Geriatr Soc Date: 2013-09-19 Impact factor: 5.562
Authors: Tamara G Fong; Noel Y Chan; Simon T Dillon; Wenxiao Zhou; Bridget Tripp; Long H Ngo; Hasan H Otu; Sharon K Inouye; Sarinnapha M Vasunilashorn; Zara Cooper; Zhongcong Xie; Edward R Marcantonio; Towia A Libermann Journal: Ann Surg Date: 2021-04-01 Impact factor: 12.969
Authors: Simon T Dillon; Sarinnapha M Vasunilashorn; Long Ngo; Hasan H Otu; Sharon K Inouye; Richard N Jones; David C Alsop; George A Kuchel; Eran D Metzger; Steven E Arnold; Edward R Marcantonio; Towia A Libermann Journal: Biol Psychiatry Date: 2016-03-25 Impact factor: 13.382
Authors: Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892
Authors: Sevdenur Cizginer; Edward Marcantonio; Sarinnapha Vasunilashorn; Alvaro Pascual-Leone; Mouhsin Shafi; Eva M Schmitt; Sharon K Inouye; Richard N Jones Journal: J Geriatr Psychiatry Neurol Date: 2017-11 Impact factor: 2.680
Authors: Sarinnapha M Vasunilashorn; Simon T Dillon; Sharon K Inouye; Long H Ngo; Tamara G Fong; Richard N Jones; Thomas G Travison; Eva M Schmitt; David C Alsop; Steven D Freedman; Steven E Arnold; Eran D Metzger; Towia A Libermann; Edward R Marcantonio Journal: J Am Geriatr Soc Date: 2017-05-26 Impact factor: 5.562